Sinopharm Group Co. Ltd. (the Company) announced that on 18 May 2023, due to attainment of the term of service of independent non-executive Directors as stipulated in the Rules of Procedure of Board of Directors of the Company, Mr. Zhuo Fumin (Mr. Zhuo) tendered his resignation as an independent non-executive Director of the Company, a member of the audit committee of the Board (the Audit Committee), and a member of the nomination committee of the Board (the Nomination Committee), which shall take effect from the appointment of his replacement at the general meeting of the Company. Mr. Zhuo has confirmed that he has no disagreement with the Board and there is no other matters relating to his resignation as a Director that needs to be brought to the attention of the shareholders of the Company (the Shareholders) and creditors of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.55 HKD | +1.35% | +8.67% | +10.27% |
May. 15 | China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection | MT |
May. 14 | China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.27% | 9.01B | |
+19.13% | 71.7B | |
-3.66% | 23.73B | |
+11.24% | 8.72B | |
-18.91% | 8.29B | |
+16.00% | 5B | |
+17.83% | 4.48B | |
-2.11% | 4.08B | |
-1.72% | 3.92B | |
+27.53% | 3.8B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm Group Co. Ltd. Announces Resignation of Zhuo Fumin as Independent Non-Executive Director